SHAB published 6 Dec 2024 · legal date 15 Nov 2024
Capital increase
Not assessed
Paid in cash
Nominal capital
100’000 → 120’000
Shares
— → 120’000
New shares, % of post-step shares
— (share counts not published)
Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 120'000, divisé en 120'000 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts.
SHAB published 11 Dec 2025 · legal date 2 Dec 2025
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
120’000 → 166’667
Shares
120’000 → 166’667
New shares, % of post-step shares
28.0% (46’667 new)
Nouveau capital-actions entièrement libéré: CHF 166'667, divisé en 166'667 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability